Aenitis Technologies
Eric Garnier is an accomplished executive with extensive experience in strategic committees across various industries. Currently serving as President of the Strategic Committee at Aenitis Technologies and a member of several strategic committees for organizations including GAOMA Therapeutics, WILCO, and BrainTale, Garnier also holds leadership positions as President at Asgardia Conseil and Angels Santé. Additionally, Garnier has served as a Senior Advisor and committee member at SEPARATIVE and has been involved in guiding health technology initiatives through SentinHealth. An MBA graduate from ISG Institut Supérieur de Gestion, Garnier further enhanced expertise with a board membership certification from emlyon business school.
This person is not in any teams
This person is not in any offices
Aenitis Technologies
1 followers
Aenitis Technologies is a spin-off of the Centre National de la Recherche Scientifique (CNRS) and the Laboratory of Physics and Mechanics of Heterogeneous Environments (PMMH) of the Graduate School of Industrial Physics and Chemistry of the City of Paris (ESPCI) specializing in developing innovative solutions for separation, handling and filtration of biological particles in suspension or not based on acoustophoresis technologies. The company initially focused on medical issues where its technological solutions bring innovation breaks with current practices.